Cargando…

Patient knowledge and pulmonary medication adherence in adult patients with cystic fibrosis

BACKGROUND AND OBJECTIVES: Patient knowledge of lung function (ie, forced expiratory volume in 1 s [FEV(1)]% predicted) and the intended benefits of their prescribed pulmonary medications might play an important role in medication adherence, but this relationship has not been examined previously in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ann Hsu-An, Kendrick, Jennifer G, Wilcox, Pearce G, Quon, Bradley S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383089/ https://www.ncbi.nlm.nih.gov/pubmed/28408806 http://dx.doi.org/10.2147/PPA.S129088

Ejemplares similares

Evaluating Adult Cystic Fibrosis Care in BC: Disparities in Access to a Multidisciplinary Treatment Centre
por: Roberts, James M., et al.
Publicado: (2016)

Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis
por: Quon, Bradley S., et al.
Publicado: (2014)

The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
por: Sergeev, Valentine, et al.
Publicado: (2020)

Experience to date with CFTR modulators during pregnancy and breastfeeding in the British Columbia Cystic Fibrosis clinic
por: Goodwin, Jodi, et al.
Publicado: (2022)

Optic Disc Swelling and Vision Loss in a Patient with Cystic Fibrosis and Diabetes
por: Iosfina, Ioulia, et al.
Publicado: (2013)

Cystic Fibrosis Respiratory Microbiology Monitoring during a Global Pandemic: Lessons Learned from a Shift to Telehealth
por: Franciosi, Alessandro N., et al.
Publicado: (2022)

Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes
por: Lam, Grace Y., et al.
Publicado: (2021)

Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations
por: Sharma, Ashutosh, et al.
Publicado: (2017)

Diagnostic agreement among experts assessing adults presenting with possible cystic fibrosis: need for improvement and implications for patient care
por: Franciosi, Alessandro N., et al.
Publicado: (2022)

Short-term effects of Lumacaftor/Ivacaftor (Orkambi™) on exertional symptoms, exercise performance, and ventilatory responses in adults with cystic fibrosis
por: Quon, Bradley S., et al.
Publicado: (2020)

Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018)

Nontuberculous Mycobacteria in Cystic Fibrosis
por: Skolnik, Kate, et al.
Publicado: (2016)

The relationship of systemic inflammation to prior hospitalization in adult patients with cystic fibrosis
por: Ngan, David A, et al.
Publicado: (2012)

Worsening pulmonary outcomes during sex reassignment therapy in a transgender female with cystic fibrosis (CF) and asthma/allergic bronchopulmonary aspergillosis: a case report
por: Lam, G. Y., et al.
Publicado: (2020)

Nebulized levofloxacin for chronic Burkholderia cenocepacia pulmonary infection in cystic fibrosis: A case report
por: Dagenais, Renée VE., et al.
Publicado: (2022)

Metabolomic Biomarkers to Predict and Diagnose Cystic Fibrosis Pulmonary Exacerbations: A Systematic Review
por: Nguyen, Anna-Lisa V., et al.
Publicado: (2022)

Supporting medication adherence for adults with cystic fibrosis: a randomised feasibility study
por: Hind, Daniel, et al.
Publicado: (2019)

TeleHealth or TeleWealth? Equity challenges for the future of cystic fibrosis care (Commentary)()
por: Franciosi, Alessandro N, et al.
Publicado: (2021)

Falling through the Cracks—The Impact of Care Gaps on Lung Function Loss in Cystic Fibrosis
por: Love, Allison J., et al.
Publicado: (2023)

Adherence to medication in adults with Cystic Fibrosis: An investigation using objective adherence data and the Theoretical Domains Framework
por: Arden, Madelynne A., et al.
Publicado: (2019)

Feasibility study for supporting medication adherence for adults with cystic fibrosis: mixed-methods process evaluation
por: Hind, Daniel, et al.
Publicado: (2020)

Identification of novel blood biomarkers of treatment response in cystic fibrosis pulmonary exacerbations by label-free quantitative proteomics
por: Dong, Kang, et al.
Publicado: (2019)

Validation of a Cystic Fibrosis Medication Knowledge Questionnaire
por: FitzPatrick, Beverly, et al.
Publicado: (2017)

Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review
por: Dagenais, Renée V. E., et al.
Publicado: (2020)

Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis
por: Bishay, Lara C, et al.
Publicado: (2016)

Reply: Predictors of Reduced Survival for Adult-diagnosed Cystic Fibrosis: Older Age at Diagnosis, a Substitute for Older Age?
por: Desai, Sameer, et al.
Publicado: (2019)

Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub
por: Arden, M. A., et al.
Publicado: (2021)

Impact of health-system specialty pharmacy services on medication adherence in pediatric patients with cystic fibrosis
por: Tao, Vincent, et al.
Publicado: (2019)

Pulmonary Nocardiosis in an Immunocompetent Patient with Cystic Fibrosis
por: Schoen, Lucy, et al.
Publicado: (2015)

Pulmonary Tuberculosis in a Patient with Cystic Fibrosis
por: Patil, Naveen, et al.
Publicado: (2015)

Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial
por: Wildman, Martin J, et al.
Publicado: (2022)

Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate “normative adherence”
por: Hoo, Zhe Hui, et al.
Publicado: (2016)

Immunomodulatory function of the cystic fibrosis modifier gene BPIFA1
por: Saferali, Aabida, et al.
Publicado: (2020)

Global burden of nontuberculous mycobacteria in the cystic fibrosis population: a systematic review and meta-analysis
por: Prieto, Miguel D., et al.
Publicado: (2023)

Factors associated with frequent high-cost individuals with cystic fibrosis and their healthcare utilization and cost patterns
por: Desai, Sameer, et al.
Publicado: (2023)

A Systematic Review of the Clinical Efficacy and Safety of CFTR Modulators in Cystic Fibrosis
por: Habib, Al-Rahim R., et al.
Publicado: (2019)

Barriers to adherence in adolescents and young adults with cystic fibrosis: a questionnaire study in young patients and their parents
por: Bregnballe, Vibeke, et al.
Publicado: (2011)

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
por: Sawant, Akhil, et al.
Publicado: (2018)

Use of medical marijuana in cystic fibrosis patients
por: Stephen, Michael J., et al.
Publicado: (2020)

Whole blood RNA-seq demonstrates an increased host immune response in individuals with cystic fibrosis who develop nontuberculous mycobacterial pulmonary disease
por: Prieto, Miguel Dario, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_clv7hdqg07e0j2fbm4250p336g